Insider · CIK 0001849673
Deborah Birx
Files at ARMP (Armata Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Deborah Birx files SEC Form 4 as CEO and director at ARMP (Armata Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Deborah Birx has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | ARMP Armata Pharmaceuticals, Inc. | FTax withholding Common Stock | -14,041 | $4.26 | $60k | 198,417 | Jul 14, 2026 |
| Mar 14, 2026 | ARMP Armata Pharmaceuticals, Inc. | FTax withholding Common Stock | -4,919 | $10.54 | $52k | 212,458 | Mar 17, 2026 |
| Mar 9, 2026 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +421,226 | $0.00 | $0 | 421,226 | Mar 11, 2026 |
| Jul 10, 2025 | ARMP Armata Pharmaceuticals, Inc. | FTax withholding Common Stock | -13,637 | $2.27 | $31k | 217,377 | Jul 14, 2025 |
| Jul 10, 2024 | ARMP Armata Pharmaceuticals, Inc. | FTax withholding Common Stock | -22,925 | $2.68 | $61k | 237,075 | Apr 25, 2025 |
| Mar 14, 2025 | ARMP Armata Pharmaceuticals, Inc. | FTax withholding Common Stock | -6,061 | $1.95 | $12k | 231,014 | Apr 25, 2025 |
| Feb 5, 2025 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +240,000 | $0.00 | $0 | 240,000 | Feb 7, 2025 |
| Mar 14, 2024 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 260,000 | Mar 18, 2024 |
| Mar 14, 2024 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +240,000 | $0.00 | $0 | 240,000 | Mar 18, 2024 |
| Dec 21, 2023 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Common Stock | +200,000 | $0.00 | $0 | 200,000 | Dec 26, 2023 |
| Dec 21, 2023 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Dec 26, 2023 |
Questions about Deborah Birx
Answered from the filings on this page, as of the latest one.
Is Deborah Birx buying or selling?
Deborah Birx has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Deborah Birx's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Deborah Birx has 0.
Where does Deborah Birx file Form 4?
Deborah Birx has filed Form 4 at ARMP (Armata Pharmaceuticals, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.